New York: UN refugee agency UNHCR, on Thursday welcomed the growing number of countries that have offered COVID-19 vaccines to refugees before urging others to do the same.
Dhaka: The Bangladesh Medical Research Council (BMRC) has decided to allow the Bangavax vaccine, a coronavirus vaccine produced by Bangladeshi company Globe Biotech, to be tested on human ...
New York: The number of new COVID-19 cases reported to the UN health agency has declined for seven weeks in a row, in what the top official there called on Monday “the longest seque ...
London: New analysis by PHE shows for the first time that 2 doses of COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant, Public Health Engla ...
New York: Even though COVID-19 cases and deaths have declined in recent weeks, the world is facing a “two-track pandemic”, the UN’s top health official said on Monday in ...
Authorities in the Maldives have given emergency use approval to Covid-19 vaccines of Moderna and Johnson & Johnson--both of them are already approved by the World Health Organization ...
Locals are rushing to get their COVID-19 vaccine jabs as two provinces reported the country’s first cases of community transmission in over three weeks, media reports said on Monday ...
New York: Although the outlook for global growth has improved, the ongoing impacts of the COVID-19 pandemic, as well as inadequate progress on vaccination in poorer countries, are putting ...
In the wake of uncertainty over getting purchased doses from India, Bangladesh has decided to join China’s COVID-19 vaccine storage facility for South Asia, bdnews24 reported.
- One dose of Sputnik V reduces mortality rate in people aged over 60 by 70-80 pc, reveals study
- 91 countries now offer COVID-19 vaccinations to refugees, says UNHCR
- Bangladesh: Authorities clear homegrown Bangavax coronavirus vaccine for clinical trial with conditions
- COVID-19 cases drop for seventh week, but deaths fall less slowly: WHO
- Two doses of COVID-19 vaccines are highly effective against hospitalisation from Delta variant: PHE